The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs

Clinical Biochemistry

Volumn 44, Issue 1, 2011, Pages 14-20

  Taylor, Paul J ^a   Tai, Chun Hui ^a   Franklin, Michael E ^a   Pillans, Peter I ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Antiretrovirals; HPLC; Immunosuppressants; Review; Tandem mass spectrometry; Therapeutic drug monitoring

Indexed keywords

ABACAVIR; AMPRENAVIR; ATAZANAVIR; CYCLOSPORIN; DARUNAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; EVEROLIMUS; FOSAMPRENAVIR; INDINAVIR; LAMIVUDINE; LOPINAVIR; MARAVIROC; MYCOPHENOLIC ACID; NELFINAVIR; NEVIRAPINE; RALTEGRAVIR; RAPAMYCIN; SAQUINAVIR; STAVUDINE; TACROLIMUS; TENOFOVIR; TIPRANAVIR; ZALCITABINE; ZIDOVUDINE;

AREA UNDER THE CURVE; CLINICAL ASSESSMENT; DRUG MONITORING; ELECTROSPRAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SALIVA; TANDEM MASS SPECTROMETRY;

ANTI-RETROVIRAL AGENTS; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TANDEM MASS SPECTROMETRY;

EID: 78650903858     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.06.012     Document Type: Review

References (90)

1. Bowers L.D. Analytical goals in therapeutic drug monitoring. Clin Chem 1998, 44:375-380.
2. Vogeser M., Parhofer K.G. Liquid chromatography tandem-mass spectrometry (LC-MS/MS)-technique and applications in endocrinology. Exp Clin Endocrinol Diab 2007, 115:559-570.
3. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific?. Clin Chem 1999, 45:371-381.
4. Cogill J.L., Taylor P.J., Westley I.S., Morris R.G., Lynch S.V., Johnson A.G. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 1998, 44:1942-1946.
5. Hermida J., Tutor J.C. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results. Ther Drug Monit 2009, 31:269-272.
6. Bruins A.P., Covey T.R., Henion J.D. Ion spray interface for combined liquid chromatography/atmospheric pressure ionization mass spectrometry. Anal Chem 1987, 59:2642-2646.
7. Fenn J.B., Mann M., Meng C.K., Wong S.F., Whitehouse C.M. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246:64-71.
8. Saint-Marcoux F., Sauvage F.L., Marquet P. Current role of LC-MS in therapeutic drug monitoring. Anal Bioanal Chem 2007, 388:1327-1349.
9. Checa A., Oliver R., Hernandez-Cassou S., Saurina J. Determination of HIV drugs in biological matrices: a review. Anal Chim Acta 2009, 647:1-13.
10. Korecka M., Shaw L.M. Review of the newest HPLC methods with mass spectrometry detection for determination of immunosuppressive drugs in clinical practice. Ann Transplant 2009, 14:61-72.
11. Yang Z., Wang S. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants. J Immunol Meth 2008, 336:98-103.
12. Oellerich M., Armstrong V.W. The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments. Ther Drug Monit 2006, 28:720-725.
13. Shaw L.M., Korecka M., Venkataramanan R., Goldberg L., Bloom R., Brayman K.L. Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant 2003, 3:534-542.
14. Cox V.C., Ensom M.H. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?. Ther Drug Monit 2003, 25:137-157.
15. Rostaing L., Cointault O., Marquet P., Josse A.G., Lavit M., Saint-Marcoux F., et al. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards. Transpl Int 2009.
16. Moscato D., Nonnato A., Adamo R., Vancheri M., Caropreso A. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment. Clin Chim Acta 2010, 411:77-80.
17. Tomita T., Homma M., Yuzawa K., Ohkohchi N., Hori T., Kaneko M., et al. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring. Ther Drug Monit 2005, 27:94-97.
18. Khoschsorur G. Simultaneous measurement of sirolimus and everolimus in whole blood by HPLC with ultraviolet detection. Clin Chem 2005, 51:1721-1724.
19. Baldelli S., Zenoni S., Merlini S., Perico N., Cattaneo D. Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection. Clin Chim Acta 2006, 364:354-358.
20. Musuamba F.T., Di Fazio V., Vanbinst R., Wallemacq P. A fast ultra-performance liquid chromatography method for simultaneous quantification of mycophenolic acid and its phenol- and acyl-glucuronides in human plasma. Ther Drug Monit 2009, 31:110-115.
21. Taylor P.J. Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry. Ther Drug Monit 2004, 26:215-219.
22. Ansermot N., Fathi M., Veuthey J.L., Desmeules J., Rudaz S., Hochstrasser D. Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry. Clin Biochem 2008, 41:728-735.
23. Kaiser P., Akerboom T., Wood W.G., Reinauer H. A new approach for the determination of immunosuppressive drugs using HPLC-MS/MS and Cs adducts. Ger Med Sci 2006, 4. Doc01.
24. Salm P., Taylor P.J., Rooney F. A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood. Ther Drug Monit 2008, 30:292-300.
25. Seger C., Tentschert K., Stoggl W., Griesmacher A., Ramsay S.L. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc 2009, 4:526-534.
26. Meinitzer A., Gartner G., Pilz S., Stettin M. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin a, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus. Ther Drug Monit 2010, 32:61-66.
27. Bogusz M.J., Enazi E.A., Hassan H., Abdel-Jawaad J., Ruwaily J.A., Tufail M.A. Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 850:471-480.
28. Koster R.A., Dijkers E.C., Uges D.R. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit 2009, 31:116-125.
29. Taylor P.J., Franklin M.E., Graham K.S., Pillans P.I. A HPLC-mass spectrometric method suitable for the therapeutic drug monitoring of everolimus. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 848:208-214.
30. Korecka M., Solari S.G., Shaw L.M. Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement. Ther Drug Monit 2006, 28:484-490.
31. Taylor P.J. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 2005, 38:328-334.
32. Taylor P.J., Brown S.R., Cooper D.P., Salm P., Morris M.R., Pillans P.I., et al. Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry. Clin Chem 2005, 51:1890-1893.
33. Brandhorst G., Streit F., Goetze S., Oellerich M., Armstrong V.W. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites. Clin Chem 2006, 52:1962-1964.
34. Kuhn J., Prante C., Kleesiek K., Gotting C. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Clin Biochem 2009, 42:83-90.
35. Benoit-Biancamano M.O., Caron P., Levesque E., Delage R., Couture F., Guillemette C. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 858:159-167.
36. Figurski M.J., Korecka M., Fields L., Waligorska T., Shaw L.M. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites. Ther Drug Monit 2009, 31:717-726.
37. Difrancesco R., Frerichs V., Donnelly J., Hagler C., Hochreiter J., Tornatore K.M. Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 859:42-51.
38. Ceglarek U., Casetta B., Lembcke J., Baumann S., Fiedler G.M., Thiery J. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants. Clin Chim Acta 2006, 373:168-171.
39. Ceglarek U., Lembcke J., Fiedler G.M., Werner M., Witzigmann H., Hauss J.P., et al. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta 2004, 346:181-190.
40. Vogeser M., Zachoval R., Spohrer U., Jacob K. Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug Monit 2001, 23:722-724.
41. Webb N.J., Roberts D., Preziosi R., Keevil B.G. Fingerprick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry. Pediatr Transplant 2005, 9:729-733.
42. Keevil B.G., Fildes J., Baynes A., Yonan N. Liquid chromatography-mass spectrometry measurement of tacrolimus in finger-prick samples compared with venous whole blood samples. Ann Clin Biochem 2009, 46:144-145.
43. Yonan N., Martyszczuk R., Machaal A., Baynes A., Keevil B.G. Monitoring of cyclosporine levels in transplant recipients using self-administered fingerprick sampling. Clin Transpl 2006, 20:221-225.
44. Keevil B.G., Tierney D.P., Cooper D.P., Morris M.R., Machaal A., Yonan N. Simultaneous and rapid analysis of cyclosporin A and creatinine in finger prick blood samples using liquid chromatography tandem mass spectrometry and its application in C2 monitoring. Ther Drug Monit 2002, 24:757-767.
45. Edelbroek P.M., van der Heijden J., Stolk L.M. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit 2009, 31:327-336.
46. Hoogtanders K., van der Heijden J., Christiaans M., van de Plas A., van Hooff J., Stolk L. Dried blood spot measurement of tacrolimus is promising for patient monitoring. Transplantation 2007, 83:237-238.
47. van der Heijden J., de Beer Y., Hoogtanders K., Christiaans M., de Jong G.J., Neef C., et al. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. J Pharm Biomed Anal 2009, 50:664-670.
48. Cheung C.Y., van der Heijden J., Hoogtanders K., Christiaans M., Liu Y.L., Chan Y.H., et al. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation. Transpl Int 2008, 21:140-145.
49. Hoogtanders K., van der Heijden J., Christiaans M., Edelbroek P., van Hooff J.P., Stolk L.M. Therapeutic drug monitoring of tacrolimus with the dried blood spot method. J Pharm Biomed Anal 2007, 44:658-664.
50. Wilhelm A.J., den Burger J.C., Vos R.M., Chahbouni A., Sinjewel A. Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:1595-1598.
51. Benech H., Hascoet S., Furlan V., Pruvost A., Durrbach A. Development and validation of an LC/MS/MS assay for mycophenolic acid in human peripheral blood mononuclear cells. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 853:168-174.
52. Ansermot N., Fathi M., Veuthey J.L., Desmeules J., Hochstrasser D., Rudaz S. Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 857:92-99.
53. Capron A., Musuamba F., Latinne D., Mourad M., Lerut J., Haufroid V., et al. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells. Ther Drug Monit 2009, 31:178-186.
54. Sandborn W.J., Lawson G.M., Cody T.J., Porayko M.K., Hay J.E., Gores G.J., et al. Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue. Hepatology 1995, 21:70-76.
55. Capron A., Lerut J., Verbaandert C., Mathys J., Ciccarelli O., Vanbinst R., et al. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection. Ther Drug Monit 2007, 29:340-348.
56. Nowak I., Shaw L.M. Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin Chem 1995, 41:1011-1017.
57. Mendonza A.E., Gohh R.Y., Akhlaghi F. Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry. Ther Drug Monit 2006, 28:402-406.
58. Shen B., Li S., Zhang Y., Yuan X., Fan Y., Liu Z., et al. Determination of total, free and saliva mycophenolic acid with a LC-MS/MS method: application to pharmacokinetic study in healthy volunteers and renal transplant patients. J Pharm Biomed Anal 2009, 50:515-521.
59. Bazzoli C., Jullien V., Le Tiec C., Rey E., Mentre F., Taburet A.M. Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action. Clin Pharmacokinet 2010, 49:17-45.
60. Back D., Gatti G., Fletcher C., Garaffo R., Haubrich R., Hoetelmans R., et al. Therapeutic drug monitoring in HIV infection: current status and future directions. AIDS 2002, 16(Suppl 1):S5-S37.
61. Aarnoutse R.E., Schapiro J.M., Boucher C.A., Hekster Y.A., Burger D.M. Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?. Drugs 2003, 63:741-753.
62. Back D., Gibbons S., Khoo S. An update on therapeutic drug monitoring for antiretroviral drugs. Ther Drug Monit 2006, 28:468-473.
63. Boffito M., Acosta E., Burger D., Fletcher C.V., Flexner C., Garaffo R., et al. Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs. Antivir Ther 2005, 10:469-477.
64. Fayet A., Beguin A., Zanolari B., Cruchon S., Guignard N., Telenti A., et al. A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:1057-1069.
65. Gehrig A.K., Mikus G., Haefeli W.E., Burhenne J. Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma. Rapid Commun Mass Spectrom 2007, 21:2704-2716.
66. Jung B.H., Rezk N.L., Bridges A.S., Corbett A.H., Kashuba A.D. Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2007, 21:1095-1104.
67. Le Saux T., Chhun S., Rey E., Launay O., Weiss L., Viard J.P., et al. Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 865:81-90.
68. Quaranta S., Woloch C., Paccou A., Giocanti M., Solas C., Lacarelle B. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples. Ther Drug Monit 2009, 31:695-702.
69. Delahunty T., Bushman L., Robbins B., Fletcher C.V. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:1907-1914.
70. ter Heine R., Alderden-Los C.G., Rosing H., Hillebrand M.J., van Gorp E.C., Huitema A.D., et al. Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2007, 21:2505-2514.
71. Ter Heine R., Rosing H., van Gorp E.C., Mulder J.W., Beijnen J.H., Huitema A.D. Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 2009, 49:393-400.
72. Bonfiglio R., King R.C., Olah T.V., Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom 1999, 13:1175-1185.
73. Martin J., Deslandes G., Dailly E., Renaud C., Reliquet V., Raffi F., et al. A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:3072-3082.
74. Merschman S.A., Vallano P.T., Wenning L.A., Matuszewski B.K., Woolf E.J. Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 857:15-24.
75. Smith P.F., DiCenzo R., Morse G.D. Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors. Clin Pharmacokinet 2001, 40:893-905.
76. Fayet A., Beguin A., de Tejada B.M., Colombo S., Cavassini M., Gerber S., et al. Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction. Ther Drug Monit 2008, 30:511-522.
77. Ehrhardt M., Mock M., Haefeli W.E., Mikus G., Burhenne J. Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma, and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 850:249-258.
78. DiFrancesco R., DiCenzo R., Vicente G., Donnelly J., Martin T.M., Colon L.A., et al. Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry. J Pharm Biomed Anal 2007, 44:1139-1146.
79. ter Heine R., Davids M., Rosing H., van Gorp E.C., Mulder J.W., van der Heide Y.T., et al. Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:575-580.
80. Elens L., Veriter S., Yombi J.C., Di Fazio V., Vanbinst R., Lison D., et al. Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:1805-1814.
81. Coulier L., van Kampen J.J.A., de Groot R., Gerritsen H.W., Bas R.C., van Dongen W.D., et al. Simultaneous determination of endogenous deoxynucleotides and phosphorylated nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cells using ion-pair chromatography coupled to mass spectrometry. Proteomics Clin Appl 2008, 2:1557-1562.
82. Fromentin E., Gavegnano C., Obikhod A., Schinazi R.F. Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry. Anal Chem 2010, 82:1982-1989.
83. Koal T., Burhenne H., Romling R., Svoboda M., Resch K., Kaever V. Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2005, 19:2995-3001.
84. ter Heine R., Rosing H., van Gorp E.C., Mulder J.W., van der Steeg W.A., Beijnen J.H., et al. Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 867:205-212.
85. Lorello G., la Porte C., Pilon R., Zhang G., Karnauchow T., MacPherson P. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV Med 2009, 10:548-554.
86. Yilmaz A., Izadkhashti A., Price R.W., Mallon P.W., De Meulder M., Timmerman P., et al. Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals. AIDS Res Hum Retroviruses 2009, 25:457-461.
87. Huang Y., Gandhi M., Greenblatt R.M., Gee W., Lin E.T., Messenkoff N. Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. Rapid Commun Mass Spectrom 2008, 22:3401-3409.
88. Rezk N.L., Abdel-Megeed M.F., Kashuba A.D. Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk. Ther Drug Monit 2007, 29:429-436.
89. Rezk N.L., White N., Bridges A.S., Abdel-Megeed M.F., Mohamed T.M., Moselhy S.S., et al. Studies on antiretroviral drug concentrations in breast milk: validation of a liquid chromatography-tandem mass spectrometric method for the determination of 7 anti-human immunodeficiency virus medications. Ther Drug Monit 2008.
90. Kunz A., Frank M., Mugenyi K., Kabasinguzi R., Weidenhammer A., Kurowski M., et al. Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration. J Antimicrob Chemother 2009, 63:170-177.